Patient#	Sample#	IL12B:(IL12B, protein),	IL2:(IL2, protein),	JAK2:(JAK2, protein),	SOCS3:(SOCS3, protein),	STAT1:(STAT1, protein),	STAT3:(STAT3, protein),	STAT4:(STAT4, protein),	STAT5A:(STAT5A, protein),	ALOX12B:(ALOX12B, protein),	CCL2:(CCL2, protein),	CD3E:(CD3E, protein),	CD4:(CD4, protein),	CXCL1:(CXCL1, protein),	CXCL9:(CXCL9, protein),	IFNG:(IFNG, protein),	IL17A:(IL17A, protein),	IL17F:(IL17F, protein),	IL19:(IL19, protein),	IL1B:(IL1B, protein),	IL23	positive regulation of dendritic cell antigen processing and presentation:(IL23, active),	IL23/IL23R/JAK2/TYK2	IL23/IL23R/JAK2/TYK2/SOCS3:(IL23/IL23R/JAK2/TYK2, active),(SOCS3, active),	NF kappa B1 p50/RelA/I kappa B alpha:(IL23/IL23R/JAK2/TYK2, active),	PI3K:(IL23/IL23R/JAK2/TYK2, active),	STAT1 (dimer):(IL23/IL23R/JAK2/TYK2, active),(STAT1, active),	STAT3/STAT4:(IL23/IL23R/JAK2/TYK2, active),(STAT3, active),(STAT4, active),	STAT4 (dimer):(IL23/IL23R/JAK2/TYK2, active),(STAT4, active),	STAT5A (dimer):(IL23/IL23R/JAK2/TYK2, active),(STAT5A, active),	T cell proliferation:(IL23/IL23R/JAK2/TYK2, active),(memory T cell differentiation, active),	keratinocyte proliferation:(IL23/IL23R/JAK2/TYK2, active),	positive regulation of chronic inflammatory response:(IL23/IL23R/JAK2/TYK2, active),	positive regulation of humoral immune response:(IL23/IL23R/JAK2/TYK2, active),	positive regulation of T cell mediated cytotoxicity:(IL23/IL23R/JAK2/TYK2, active),	STAT3 (dimer):(IL23/IL23R/JAK2/TYK2, active),(PI3K, active),(STAT3, active),	IL23R:(IL23R, protein),	IL24:(IL24, protein),	IL6:(IL6, protein),	MPO:(MPO, protein),	NOS2:(NOS2, protein),	TNF:(TNF, protein),	ITGA3:(ITGA3, protein),	IL23R/JAK2:(IL23R, active),(JAK2, active),	IL23A:(IL23A, protein),	
